- Research works
- 19 ▲ 1375% vs 2018-21
- Citations
- 201 10.4 per fractional work
- Top-10% rate
- 6.0% all institutions 10.0%
- Open access
- 29% world 40%
- International
- 29% world 18%
Not ranked overall: Vicore Pharma (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Vicore Pharma (Sweden) work in?
In all years, 65% of research at Vicore Pharma (Sweden) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (64%), Agricultural and Biological Sciences (13%), Economics, Econometrics and Finance (11%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences1365.1%
- Medicine1264.3%
- Health Professions00.6%
- Nursing00.2%
- Life Sciences318.0%
- Social Sciences212.7%
- Economics, Econometrics and Finance211.2%
- Social Sciences00.9%
- Psychology00.6%
- Physical Sciences14.3%
- Materials Science02.6%
- Mathematics01.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.1×. Every wedge is a field page.
All 10 fields, with their numbers
- Economics, Econometrics and Finance7.06×2 works
- Medicine3.82×11 works
- Mathematics1.96×0 works
- Immunology and Microbiology1.22×0 works
- Biochemistry, Genetics and Molecular Biology0.77×1 works
- Nursing0.59×0 works
- Health Professions0.29×0 works
- Psychology0.25×0 works
- Agricultural and Biological Sciences0.16×0 works
- Social Sciences0.09×0 works
Who are the top researchers at Vicore Pharma (Sweden)?
Ranked on the quality score, Rohit Batta lead among researchers whose main affiliation is Vicore Pharma (Sweden).
- 1
Rohit Batta
Sweden · #3,184,056 worldwide 197 citations · 22 works
Which research topics does Vicore Pharma (Sweden) publish most on?
By volume in 2022-now: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension Research and Treatments, Health Systems, Economic Evaluations, Quality of Life and Respiratory and Cough-Related Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 2 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 6 Folate and B Vitamins Research Rheumatology 0 works
- 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 9 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
- 10 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Vicore Pharma (Sweden)'s research output changed?
Output in 2022-2025 was 1375% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Vicore Pharma (Sweden) as a percentage of every work published that year, 0.000048% in 2024.
Fractional works of Vicore Pharma (Sweden) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Mölndal
- Profu (Sweden)
- Dentsply Sirona (Sweden)
- Antaros Medical (Sweden)
- Institute for Quality Indicators (Sweden)
- Setek Elektronik (Sweden)
- Metso (Sweden)
- I-Tech (Sweden)
- Integrum (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Vicore Pharma (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.